Answers are grounded in this paper and cite their sources.
// Gennaro Chiappetta 1, * , Teresa Valentino 2, * , Michela Vitiello 2 , Rosa Pasquinelli 1 , Mario Monaco 1 , Giuseppe Palma 3 , Romina Sepe 2, 4 , Antonio Luciano 3 , Pierlorenzo Pallante 2 , Dario Palmieri 5 , Concetta Aiello 1 , Domenica Rea 3 , Simona Nunzia Losito 1 , Claudio Arra 3 , Alfredo Fusco 2, 4 , Monica Fedele 2 1 Department of Experimental Oncology, Functional Genomic Unit, National Cancer Institute “Fondazione Giovanni Pascale”, IRCCS, 80131 Naples, Italy 2 Institute of Experimental Endocrinology and Oncology (IEOS), National Research Counsil (CNR), 80131 Naples, Italy 3 Animal Facility, National Cancer Institute “Fondazione Giovanni Pascale”, IRCCS, 80131 Naples, Italy 4 Department of Molecular Medicine and Medical Biotechnologies, University of Naples “Federico II”, 80131 Naples, Italy 5 Departments of Molecular Virology, Immunology and Human Genetics, Comprehensive Cancer Center, Ohio State University, Columbus, OH 43210, USA * These authors have contributed equally to this work Correspondence to: Monica Fedele, e-mail: mfedele@unina.it Gennaro Chiappetta, e-mail: g.chiappetta@istitutotumori.na.it Keywords: thyroid cancer, PATZ1, Epithelial-Mesenchymal Transition, cell migration Received: July 22, 2014 Accepted: November 18, 2014 Published: December 16, 2014 ABSTRACT PATZ1, a POZ-Zinc finger protein, is emerging as an important regulator of development and cancer, but its cancer-related function as oncogene or tumor-suppressor is still debated. Here, we investigated its possible role in thyroid carcinogenesis. We demonstrated PATZ1 is down-regulated in thyroid carcinomas compared to normal thyroid tissues, with an inverse correlation to the degree of cell differentiation. In fact, PATZ1 expression was significantly further down-regulated in poorly differentiated and anaplastic thyroid cancers compared to the papillary histotype, and it resulted increasingly delocalized from the nucleus to the cytoplasm proceeding from differentiated to undifferentiated thyroid carcinomas. Restoration of PATZ1 expression in three thyroid cancer-derived cell lines, all characterized by fully dedifferentiated cells, significantly inhibited their malignant behaviors, including in vitro proliferation, anchorage-independent growth, migration and invasion, as well as in vivo tumor growth. Consistent with recent studies showing a role for PATZ1 in the p53 pathway, we showed that ectopic expression of PATZ1 in thyroid cancer cells activates p53-dependent pathways opposing epithelial-mesenchymal transition and cell migration to prevent invasiveness. These results provide insights into a potential tumor-suppressor role of PATZ1 in thyroid cancer progression, and thus may have potential clinical relevance for the prognosis and therapy of thyroid cancer.
No takes yet. Share an insight, caveat, or question.
Chiappetta et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: